| Remedium Lifecare Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 539561 |
NSE Symbol : - |
P/E(TTM) : 0.00 |
|
ISIN Demat : INE549S01036 |
Div & Yield% : 0.00 |
EPS(TTM) : 0.00 |
|
Book Value(₹) : 1.03 |
Market Cap(₹Cr) : 80.26 |
Face Value(₹) : 1.00 |
| Particulars | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 8.58 | 18.37 | 81.57 | 38.15 | 25.08 | 77.70 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 8.58 | 18.37 | 81.57 | 38.15 | 25.08 | 77.70 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 3.25 | 3.48 | 0.66 | 7.43 | 0.82 | 1.89 |
| Total Income | 11.83 | 21.85 | 82.23 | 45.58 | 25.90 | 79.59 |
| Total Expenditure | 11.57 | 22.58 | 82.75 | 43.63 | 20.62 | 77.31 |
| PBIDT | 0.26 | -0.73 | -0.52 | 1.95 | 5.28 | 2.28 |
| Interest | 0.19 | -0.36 | 1.59 | 0.88 | 2.81 | 0.00 |
| PBDT | 0.07 | -0.37 | -2.11 | 1.07 | 2.47 | 2.28 |
| Depreciation | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 |
| Tax | 0.00 | 0.00 | 0.53 | 0.29 | 0.68 | 0.63 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.00 | 0.00 | -0.01 | 0.00 | 0.00 | 0.00 |
| Reported Profit After Tax | 0.07 | -0.37 | -2.64 | 0.76 | 1.78 | 1.64 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 0.07 | -0.37 | -2.64 | 0.76 | 1.78 | 1.64 |
| EPS (Unit Curr.) | 0.00 | 0.00 | -0.07 | 0.02 | 0.04 | 0.16 |
| EPS (Adj) (Unit Curr.) | 0.00 | 0.00 | -0.05 | 0.01 | 0.03 | 0.03 |
| Calculated EPS (Unit Curr.) | 0.00 | 0.00 | -0.07 | 0.02 | 0.04 | 0.16 |
| Calculated EPS (Adj) (Unit Curr.) | 0.00 | 0.00 | -0.05 | 0.01 | 0.03 | 0.03 |
| Calculated EPS (Ann.) (Unit Curr.) | 0.00 | -0.02 | -0.26 | 0.08 | 0.18 | 0.65 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 0.00 | -0.02 | -0.18 | 0.06 | 0.13 | 0.11 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 88.20 | 88.20 | 40.32 | 40.32 | 40.32 | 10.08 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 3.03 | -3.97 | -0.64 | 5.11 | 21.05 | 2.93 |
| PBDTM(%) | 0.82 | -2.01 | -2.59 | 2.80 | 9.85 | 2.93 |
| PATM(%) | 0.82 | -2.01 | -3.24 | 1.99 | 7.10 | 2.11 |